D E Noyola
Overview
Explore the profile of D E Noyola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez-Gomez A, Sanchez-Ramos E, Noyola D
Rev Epidemiol Sante Publique
. 2021 May;
69(4):205-213.
PMID: 34023186
Background: Influenza is a major cause of mortality worldwide. Most influenza-associated deaths are associated with cardiovascular or respiratory disorders. However, a large proportion of influenza-associated deaths do not have respiratory...
2.
Negrete-Gonzalez C, Turrubiartes-Martinez E, Galicia-Cruz O, Noyola D, Martinez-Aguilar G, Perez-Gonzalez L, et al.
BMC Microbiol
. 2020 Jul;
20(1):213.
PMID: 32689948
Background: Staphylococcus aureus is a leading cause of broad-spectrum infections both in the community and within healthcare settings. Methicillin-resistant Staphylococcus aureus (MRSA) has become a global public health issue. The...
3.
Mendez-Mancilla A, Lima-Rogel V, Toro-Ortiz J, Escalante-Padron F, Monsivais-Urenda A, Noyola D, et al.
Pediatr Obes
. 2017 Oct;
13(3):168-174.
PMID: 29045034
Background: The perinatal environment has a role in the establishment of altered metabolic and inflammatory responses, and could be modulated by microRNAs regulating immune and metabolic processes. Objective: To analyze...
4.
Taboada B, Isa P, Espinoza M, Aponte F, Arias-Ortiz M, Monge-Martinez J, et al.
Genome Announc
. 2016 Nov;
4(6).
PMID: 27834708
We report the complete genome sequence of the first Mexican human coronavirus (HCoV) OC43, obtained by new-generation sequencing and a metagenomic approach, isolated from a child hospitalized with pneumonia. The...
5.
Alvarado-Hernandez D, Benitez-Sanchez A, Rodriguez-Cuevas J, Rosales-Saavedra T, Guerra-Palomares S, Comas-Garcia A, et al.
Int J Immunogenet
. 2016 Jun;
43(4):189-99.
PMID: 27277336
Human cytomegalovirus (CMV) represents an important public health concern as it is associated with severe morbidity and mortality in transplant recipients, HIV-infected individuals and pregnant women given the risk of...
6.
Gonzalez-Sanchez H, Monsivais-Urenda A, Salazar-Aldrete C, Hernandez-Salinas A, Noyola D, Jimenez-Capdeville M, et al.
J Neurovirol
. 2015 Apr;
21(4):346-57.
PMID: 25851778
Cytomegalovirus (CMV) is the most common cause of congenital infection in developed countries and a major cause of neurological disability in children. Although CMV can affect multiple organs, the most...
7.
Rangel-Ramirez V, Garcia-Sepulveda C, Escalante-Padron F, Perez-Gonzalez L, Rangel-Castilla A, Aranda-Romo S, et al.
Int J Immunogenet
. 2013 Dec;
41(2):126-30.
PMID: 24305414
Expansion of a natural killer (NK) cell population that expresses NKG2C has been associated with cytomegalovirus and other viral infections. It has been suggested that this cell population may play...
8.
Juarez-Reyes A, Noyola D, Monsivais-Urenda A, Alvarez-Quiroga C, Gonzalez-Amaro R
Clin Vaccine Immunol
. 2013 Jun;
20(8):1291-7.
PMID: 23784853
The innate immune system constitutes the first line of defense against viral agents, and NK cells seem to have an important protective role during the early phases of influenza virus...
9.
Colmenares V, Noyola D, Monsivais-Urenda A, Salgado-Bustamante M, Estrada-Capetillo L, Gonzalez-Amaro R, et al.
Clin Vaccine Immunol
. 2012 May;
19(7):1005-11.
PMID: 22573736
Human papillomavirus (HPV) is able to inhibit the secretion of gamma interferon (IFN-γ) and the expression of some immune innate cell receptors. Immunoglobulin-like transcript 2 (ILT2) is a regulatory receptor...
10.
Lima-Rogel V, Medina-Rojas E, Del Carmen Milan-Segovia R, Noyola D, Nieto-Aguirre K, Lopez-Delarosa A, et al.
J Clin Pharm Ther
. 2008 May;
33(3):295-306.
PMID: 18452417
Objective: To define the pharmacokinetic behaviour of cefepime in neonates with severe nosocomial infections using a mixed effects model. Patients And Methods: Thirty-one newborn infants were included in the study;...